The use of innovative imaging and AI techniques to address inefficiencies in haematology labs joins the ranks of OpenAI, NASA, and other organizations.
The creator of Full-Field Cell MorphologyTM imaging and analysis tools, Scopio Labs, has been included in 2023’s edition of Fast Company’s coveted list of the World’s Most Innovative Companies. The yearly list honors organizations that are reshaping industries, influencing society, and advancing the state of the world by highlighting companies at the top of their respective markets.
“It’s an honor to be recognized by Fast Company for our breakthrough Full-Field cell morphology platforms. Being included in this list is a testament to the passionate and talented team we’ve built,” said Itai Hayut, CEO and Co-Founder of Scopio Labs. “As we bring our cutting-edge digital imaging and AI solutions to the market, we remain laser-focused on our mission to raise the standard of healthcare and propel the field of hematology diagnostics forward.”
The use of manual microscopy is no longer necessary thanks to Scopio, which also offers laboratory scientists and haematologists substantial operational savings by utilizing significant advancements in AI and proprietary full-field digital imaging. Hematology and blood cell morphology analysis are being digitalized by Scopio, which also provides a suite of digital tools to help lab personnel identify blood-related tumors, anemia, infections, allergies, and other hematological-based disorders quickly and early. High-definition pictures are sent in real-time through a secure hospital network for collaboration or consultation from anywhere thanks to innovative built-in remote capabilities, ushering in the remote-work revolution in haematology and cell morphology.
Scopio made a number of noteworthy accomplishments in 2022, including raising $50 million in Series C funding and receiving 510(k) approval from the US Food and Drug Administration for its X100HT device, which allows it to serve the demands of labs of any size. A huge vote of confidence in Scopio’s Full-Field digital cell morphology platforms as the new market standard, replacing the use of the manual microscope, which has been the gold standard for decades, came in Q3 when Scopio signed a global distribution agreement with Beckman Coulter, a global leader in clinical diagnostics.
The Full-Field Bone Marrow AspirateTM (FF-BMA) Application, the first digital imaging and analysis platform for bone marrow aspirates—a crucial but notoriously difficult sample to analyze—was launched by Scopio and received the CE-Mark at the end of the year.
One of the most eagerly awaited editorial projects of the year is Fast Company’s flagship series, The World’s Most Innovative Businesses. It offers an up-close view of the creative and exciting work being done by businesses in many spheres of the economy.
“What a strange and thrilling year it has been to honor this year’s Most Innovative Companies. This year’s list compiles some of the most cutting-edge groundbreakers who are changing our world every single day, from legacy organizations like Mcdonald’s to upstarts like MrBeast and institutions such as NASA. Everyone on this list does something completely, uniquely different, yet, they all have one thing in common: innovation,” said Fast Company editor-in-chief Brendan Vaughan.
